Literature DB >> 24072491

COL1A1 polymorphism is associated with risks of osteosarcoma susceptibility and death.

Maolin He1, Zhe Wang, Jinmin Zhao, Yingbin Chen, Yang Wu.   

Abstract

Osteosarcoma is a life-threatening malignancy that often occurs in teenagers. Collagen type I alpha 1 (COL1A1) polymorphism is reportedly associated with the occurrence of several human diseases. However, the relationship between COL1A1 and osteosarcoma occurrence remains unknown, and there is no report about the prevalence of COL1A1 in osteosarcoma. The purpose of this study is to investigate the associations of COL1A1 polymorphism with the susceptibility and survival of osteosarcoma. The relative risk to develop osteosarcomas and the overall survival associated to COL1A1 polymorphism were investigated in a homogeneous group of 189 osteosarcomas patients. Correlations with overall survival and hazard ratios (HR) were also analyzed. CT genotype and C allele of COL1A1 at rs1061970, and CG genotype and G allele of COL1A1 at rs2075559 are associated with decreased susceptibility to osteosarcoma in the Chinese population. CC genotype and C allele of COL1A1 at rs1061970 are associated with nonmetastasis in patients. CC genotype and CT genotype of COL1A1 at rs1061970 are associated with lower risk of death. Metastasis was found to be an independent prognostic factor for survival. This study provides the first evidence for the association between COL1A1 polymorphism and osteosarcoma risk in Chinese and shows that COL1A1 polymorphism at rs1061970 has a prognostic value for overall survival in osteosarcoma patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24072491     DOI: 10.1007/s13277-013-1172-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  35 in total

1.  A dynamic programming algorithm for haplotype block partitioning.

Authors:  Kui Zhang; Minghua Deng; Ting Chen; Michael S Waterman; Fengzhu Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  Osteosarcoma: clinical practice and the expanding role of biology.

Authors:  R Gorlick
Journal:  J Musculoskelet Neuronal Interact       Date:  2002-12       Impact factor: 2.041

3.  A generalized log-rank test for interval-censored failure time data via multiple imputation.

Authors:  Jinlong Huang; Chinsan Lee; Qiqing Yu
Journal:  Stat Med       Date:  2008-07-30       Impact factor: 2.373

4.  Multidrug resistance and malignancy in human osteosarcoma.

Authors:  K Scotlandi; M Serra; G Nicoletti; M Vaccari; M C Manara; G Nini; L Landuzzi; A Colacci; G Bacci; F Bertoni; P Picci; M Campanacci; N Baldini
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

5.  COL1A1, ESR1, VDR and TGFB1 polymorphisms and haplotypes in relation to BMD in Spanish postmenopausal women.

Authors:  M Bustamante; X Nogués; A Enjuanes; R Elosua; N García-Giralt; L Pérez-Edo; E Cáceres; R Carreras; L Mellibovsky; S Balcells; A Díez-Pérez; D Grinberg
Journal:  Osteoporos Int       Date:  2006-10-05       Impact factor: 4.507

6.  Study of the association between polymorphisms of the COL1A1 gene and HBV-related liver cirrhosis in Chinese patients.

Authors:  Yun-Peng Zhao; Hao Wang; Meng Fang; Qiang Ji; Zai-Xing Yang; Chun-Fang Gao
Journal:  Dig Dis Sci       Date:  2008-06-07       Impact factor: 3.199

7.  Twentieth-century survival from osteosarcoma in childhood. Trends from 1933 to 2004.

Authors:  L Foster; G F Dall; R Reid; W H Wallace; D E Porter
Journal:  J Bone Joint Surg Br       Date:  2007-09

8.  Association of FGFR3 and MDM2 gene nucleotide polymorphisms with bone tumors.

Authors:  V A Naumov; E V Generozov; Yu N Solovyov; M D Aliev; N E Kushlinsky
Journal:  Bull Exp Biol Med       Date:  2012-10       Impact factor: 0.804

9.  Effect of ABCB1 and ABCC3 polymorphisms on osteosarcoma survival after chemotherapy: a pharmacogenetic study.

Authors:  Daniela Caronia; Ana Patiño-Garcia; Antonio Peréz-Martínez; Guillermo Pita; Leticia Tais Moreno; Marta Zalacain-Díez; Blanca Molina; Isabel Colmenero; Luis Sierrasesúmaga; Javier Benítez; Anna Gonzalez-Neira
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

10.  Lysyl oxidase polymorphisms and susceptibility to osteosarcoma.

Authors:  Yang Liu; Bitao Lv; Zhimin He; Yujia Zhou; Carrie Han; Guodong Shi; Rui Gao; Ce Wang; Lili Yang; Haihan Song; Wen Yuan
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.752

View more
  14 in total

1.  Role of five small nucleotide polymorphisms in the VEGF gene on the susceptibility to osteosarcoma and overall survival of patients.

Authors:  Jian-Qiang Liu; Xia Bai; DE-Chen Duan; Ai-Xia Dou
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

2.  Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.

Authors:  Yue Zhao; Yimin Wang; Fudi Zhu; Jiayu Zhang; Xiao Ma; Dongwei Zhang
Journal:  Clin Exp Med       Date:  2020-01-24       Impact factor: 3.984

3.  Effect of variation of FGF2 genotypes on the risk of osteosarcoma susceptibly: a case control study.

Authors:  Jiefeng Wang; Hongtao Liu; Xiaoyang Liu; Xiaojun Qi
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population.

Authors:  Zhen Wang; Peng Wen; Xiaojun Luo; Xiaomin Fang; Qingfeng Wang; Feng Ma; Jinhan Lv
Journal:  Tumour Biol       Date:  2013-12-06

5.  Association of RECQL5 gene polymorphisms and osteosarcoma in a Chinese Han population.

Authors:  Li-Qiang Zhi; Wei Ma; Hong Zhang; Si-Xiang Zeng; Bo Chen
Journal:  Tumour Biol       Date:  2013-11-28

6.  Genetic polymorphisms of interleukin-1 beta and osteosarcoma risk.

Authors:  Yu He; XinJun Liang; ChunQing Meng; ZengWu Shao; Yong Gao; Qiang Wu; JianXiang Liu; Hong Wang; ShuHua Yang
Journal:  Int Orthop       Date:  2014-05-31       Impact factor: 3.075

7.  Association of COL1A1 rs1800012 polymorphism with musculoskeletal degenerative diseases: a meta-analysis.

Authors:  Binlong Zhong; Donghua Huang; Kaige Ma; Xiangyu Deng; Deyao Shi; Fashuai Wu; Zengwu Shao
Journal:  Oncotarget       Date:  2017-09-08

8.  A Bayesian Gene-Based Genome-Wide Association Study Analysis of Osteosarcoma Trio Data Using a Hierarchically Structured Prior.

Authors:  Yi Yang; Saonli Basu; Lisa Mirabello; Logan Spector; Lin Zhang
Journal:  Cancer Inform       Date:  2018-05-21

9.  Associations of polymorphisms in NAT2 gene with risk and metastasis of osteosarcoma in young Chinese population.

Authors:  Zhengxiang Huang; Li Yuan; Zhenghui Jiang; Dongliang Wang
Journal:  Onco Targets Ther       Date:  2015-09-22       Impact factor: 4.147

10.  Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis.

Authors:  Clara Benna; Andrea Simioni; Sandro Pasquali; Davide De Boni; Senthilkumar Rajendran; Giovanna Spiro; Chiara Colombo; Calogero Virgone; Steven G DuBois; Alessandro Gronchi; Carlo Riccardo Rossi; Simone Mocellin
Journal:  Oncotarget       Date:  2018-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.